Đang chuẩn bị liên kết để tải về tài liệu:
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

The mTOR signalling pathway plays an important role in cancer. As a master regulator, the status of MTOR affects pathway activity and the efficacy of mTOR inhibitor therapy. However, little research has been performed to explore MTOR in colorectal cancer (CRC). |

TÀI LIỆU LIÊN QUAN

Additive methods for genomic signatures

2SigFinder: The combined use of smallscale and large-scale statistical testing for genomic island detection from a single genome

Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations

Association between genomic recurrence risk and well-being among breast cancer patients

An investigation into inter- and intragenomic variations of graphic genomic signatures

Genomic rearrangements and signatures of breeding in the allo-octoploid strawberry as revealed through an allele dose based SSR linkage map

Báo cáo y học: "Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis"

Báo cáo y học: " The use of genomic signature distance between bacteriophages and their hosts displays evolutionary relationships and phage growth cycle determination"

A key genomic signature associated with lymphovascular invasion in head and neck squamous cell carcinoma

Assessment of k-mer spectrum applicability for metagenomic dissimilarity analysis
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.